診療部-2019年

論文・執筆名 著者 共同発表者名 論文・書籍名等 出版社名等 発行年 号数等 巻号頁
The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan. Murakami W Tozaki M, Nakamura S, Ide Y, Inuzuka M, Hirota Y, Murakami K, Takahama N, Ohgiya Y, Gokan T. Breast Cancer Springer 2019 [Epub ahead of print] [Epub ahead of print]

診療部-2018年

論文・執筆名 著者 共同発表者名 論文・書籍名等 出版社名等 発行年 号数等 巻号頁
Simultaneous whole‑body and breast 18F‑FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values Michiro Sasaki Mitsuhiro Tozaki, Kazunori Kubota, Wakana Murakami, Daisuke Yotsumoto, Yasuaki Sagara, Yasuyo Ohi, Shunichi Oosako, Yoshiaki Sagara. Japanese Journal of Radiology Springer 2018 36(2) 122-133
Hybrid PET/MR Imaging of Breast Cancer: Advantages and Pitfalls K. Kubota M. Sasaki, M. Tozaki, Y.Sagara. EPOS European Society of Radiology 2018 Publis hed online
Breast MRI as a Problemsolving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing Shimauchi A Machida Y, Maeda I, Fukuma E, Hoshi K, Tozaki M. Academic radiology Springer 2018 25(3) 288-296
Randomized phase II study of anastrozole plus tegafur uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC) Takahiro Nakayama Yasuaki Sagara, Tsutomu Takashima, Nobuki Matsunami, Norikazu Masuda, Yasuo Miyoshi, Tetsuya Taguchi, Toyokazu Aono, Toshikazu Ito, Tatsuo Kagimura, Shinzaburo Noguchi Cancer Chemotherapy and Pharmacology Springer 2018 81(4) 755-762
Bi‑weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST‑STUDY) Shoichiro Ohtani Takahiro Nakayama, Tetsuhiro Yoshinami, Ken‑ichi Watanabe, Fumikata Hara, Yasuaki Sagara, Hidetoshi Kawaguchi, Kenji Higaki, Nobuki Matsunami, Yoshie Hasegawa, Masato Takahashi, Makiko Mizutani, Takashi Morimoto, Masako Sato, Mitsuya Itoh, Satoshi Morita, Norikazu Masuda Breast Cancer Springer 2018 25(4) 438-446
PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells. Kie Honjo Taiji Hamada, Takuya Yoshimura, Seiya Yokoyama, Sohsuke Yamada, Yan-Qin Tan, Lai K. Leung, Norifumi Nakamura, Yasuyo Ohi, Michiyo Higashi, Akihide Tanimoto Oncotarget Impact journals 2018 9(51) 29619-29633
Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. Yamashiro H Sawaki M, Masuda N, Okumura Y, Takano T, Tokunaga E, Saito T, Sagara Y, Yamazaki K, Kawaguchi Y, Lee T, Ozaki S, Yamagami K, Yamamoto N, Kuroi K, Suwa H, Ohtani S, Ito T, Yasuno S, Morita S, Ohno S, Toi M. Breast Cancer: Basic and Clinical Research Libertas Academica 2018 12 117822
341878
6243
Shear Wave Speed of the Lesion in Preoperative Breast Ultrasonography: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer. Machida Y Shimauchi A, Okuma H, Tozaki M, Isobe S,
Fukuma E
Academic Radiology W.B. Saunders Company 2018 25(8) 1003-1009
A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study. Onishi H Udagawa C, Kubo M, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Momozawa Y, Low SK, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Hartman M, Chan CW, Lee SC, Endo , Zembutsu H PLoS One PLOS 2018 13(8) e02016
06.
Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis. Shimazu K Sato N, Ogiya A, Sota Y, Yotsumoto D, Ishikawa T, Nakamura S, Kinoshita T, Tsuda H, Ohi Y, Akiyama F, Noguchi S. Annals of surgical oncology Springer 2018 25(9) 2603-2611
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. Yasuaki Sagara Masahiro Takada, Yasuyo Ohi, Shoichiro Ohtani, Sasagu Kurozumi, Kenichi Inoue, Yoshimasa Kosaka, Masaya Hattori, Toshinari Yamashita, Shintaro Takao, Nobuaki Sato, Hiroji Iwata, Masafumi Kurosumi, Masakazu Toi Breast Cancer Research and Treatment Springer 2018 171(3) 675-683
Does integrated shimming improve lesion detection in whole-body diffusion-weighted examinations of patients with breast cancer? Sasaki M Tozaki M, Maruyama K, Benkert T, Murakami W, Yotsumoto D, Oosako S, Sagara Y Japanese Journal of Radiology Springer 2018 36(12) 736-743
Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis. Umekita Y Ohi Y, Iwaya O, Souda M, Sagara Y, Tamada S, Yotsumoto D, Tanimoto A Histopathology John Wiley & Sons 2018 73(6) 916-922
Apocrine papillary lesion: comparison of pathological findings from 22 years previously and the present. Yuki Nomoto Heiji Yoshinaka, Yasuyo Ohi, Naoki Hayashi, Ayako Nagata, Kazunobu Sueyoshi, Yuka Eguchi, Yoshiaki Shinden, Yuko Kijima, Shoji Natsugoe Breast Cancer Springer 2018 [Epub ahead of print] [Epub ahead of print]
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study. Iwata H Masuda N, Yamamoto Y, Fujisawa T, Toyama T, Kashiwaba M, Ohtani S, Taira N, Sakai T, Hasegawa Y, Nakamura R, Akabane H, Shibahara Y, Sasano H, Yamaguchi T, Sakamaki K, Bailey H, Cherbavaz DB, Jakubowski DM, Sugiyama N, Chao C, Ohashi Y. Breast Cancer Research and Treatment Springer 2018 173 123-133
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy. Guestini F Ono K, Miyashita M, Ishida T, Ohuchi N, Nakagawa S, Hirakawa H, Tamaki K, Ohi Y, Rai Y, Sagara Y, Sasano H, McNamara KM Breast Cancer Research and Treatment Springer 2018 173(2) 275-288
Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population. Kamitani T Yabuuchi H, Kanemaki Y, Tozaki M, Sonomura T, Mizukoshi W, Nakata W, Shimono T, Urano M, Yamano T, Kato F, Kuchiki M, Shiraga N, Yanagita H, Katsuda E, Kataoka M, Yamaguchi K, Horikoshi T, Gomi T, Nozaki M, Shiotani M, Amano M, Saigusa H, Sadaoka S, Kamiya H, Kubo M, Yamashita N, Yamamoto H, Honda H. European journal of radiology ELESEVIER 2018 110 130-135

診療部-2017年

論文・執筆名 著者 共同発表者名 論文・書籍名等 出版社名等 発行年 号数等 巻号頁
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab. Nishimura R Toh U, Tanaka M, Saimura M, Okumura Y, Saito T, Tanaka T, Teraoka M, Shimada K, Katayama K, Koga T, Kurashita K, Hasegawa S, Todoroki H, Kai Y, Ohi Y, Toyoshima S, Arima N, Mitsuyama S, Tamura K. Oncology KARGER 2017 93(1) 51-61
The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy Tanaka K Tokunaga E, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Oda Y, Maehara Y. Breast Cancer Springer 2017 24(3) 384-392
Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis. Wong SM Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M. Cancer Wiley 2017 123(14) 2609-2617
Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma Kikuchi K McNamara KM, Miki Y, Moon JY, Choi MH, Omata F, Sakurai M, Onodera Y, Rai Y, Ohi Y, Sagara Y, Miyashita M, Ishida T, Ohuchi N, Sasano H. Breast Cancer Research and Treatment Springer 2017 166(3) 709-723
Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast Sagara Y Julia W, Golshan M, Toi M. Frontiers in Oncology Frontiers Media SA 2017 Publis hed online
Trends in adjuvant therapies after breast-conserving surgery for hormone receptorpositive ductal carcinoma in situ : findings from the National Cancer Database, 2004-2013 Yasuaki Sagara Rachel A. Freedman, Stephanie M. Wong, Faitih Aydogan, Anvy Nguyen, William T.Barry, Mehra Golshan. Breast Cancer Research and Treatment Springer 2017 166(2) 583-592

看護部-2017年

論文・執筆名 著者 共同発表者名 論文・書籍名等 出版社名等 発行年 号数等 巻号頁
Decision making regarding the place of end-of-life cancer care: the burden on bereaved families and related factors Yamamoto S Arao H, Masutani E, Aoki M, Kishino M, Morita T, Shima Y, Kizawa Y, Tsuneto S, Aoyama M, Miyashita M Journal of Pain and Symptom Management Elsevier 2017 5(53) 862–870

臨床検査部-2017年

論文・執筆名 著者 共同発表者名 論文・書籍名等 出版社名等 発行年 号数等 巻号頁
「乳腺粘液癌(純型,typeB)の液状化検体細胞診所見に関する検討」 永尾聡子 大井恭代、前田ゆかり、皆倉愛美、富田暢子 日本臨床細胞学会雑誌 日本臨床細胞学会 2017 Vol.56 No.6